FT

FitLife Brands IncNASDAQ FTLF Stock Report

Last reporting period 30 Jun, 2024

Updated 19 Sep, 2024

Last price

Market cap $B

0.153

Micro

Exchange

XNAS - Nasdaq

FTLF Stock Analysis

FT

Avoid

Based on Eyestock quantitative analysis, FTLF`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

75/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-60.0 %

Greatly overvalued

Market cap $B

0.153

Dividend yield

Shares outstanding

4.544 B

FitLife Brands, Inc. engages in the provision of nutritional supplements for health conscious consumers. The company is headquartered in Omaha, Nebraska and currently employs 25 full-time employees. The company went IPO on 2007-10-26. The firm provides nutritional supplements for health-conscious consumers marketed under the brand names, such as NDS Nutrition, PMD Sports, Siren Labs, Metis Nutrition, Nutrology, iSatori, Energize, BioGenetic Laboratories and Core Active. Its NDS Nutrition provides healthy trusted products to enhancing calorie burning, body toning, improve weight management, and overall balanced health. The Company’s PMD Sports Nutrition product line features professional-caliber supplements for those seeking gains in healthy and lean muscle. Its SirenLabs is providing performance-enhancing supplements, such as Shock'D Yoked, Vaso-Vol Muscle Pump Volumizer and Ultra Karbs Mass Gainer. Its Metis Nutrition products include JXT5 5-in-1 Men's Health Supplement and Pyro Stim 7 Once-A-Day Thermogenic. Its iSatori provides BIO-GRO Protein Synthesis Amplifier and MORPH x5.

View Section: Eyestock Rating